Strain Specific Resistance to Murine Scrapie Associated with a Naturally Occurring Human Prion Protein Polymorphism at Residue 171
Transmissible spongiform encephalopathies (TSE) or prion diseases are neurodegenerative disorders associated with conversion of normal host prion protein (PrP) to a misfolded, protease-resistant form (PrPres). Genetic variations of prion protein in humans and animals can alter susceptibility to both familial and infectious prion diseases. The N171S PrP polymorphism is found mainly in humans of African descent, but its low incidence has precluded study of its possible influence on prion disease. Similar to previous experiments of others, for laboratory studies we created a transgenic model expressing the mouse PrP homolog, PrP-170S, of human PrP-171S. Since PrP polymorphisms can vary in their effects on different TSE diseases, we tested these mice with four different strains of mouse-adapted scrapie. Whereas 22L and ME7 scrapie strains induced typical clinical disease, neuropathology and accumulation of PrPres in all transgenic mice at 99-128 average days post-inoculation, strains RML and 79A produced clinical disease and PrPres formation in only a small subset of mice at very late times. When mice expressing both PrP-170S and PrP-170N were inoculated with RML scrapie, dominant-negative inhibition of disease did not occur, possibly because interaction of strain RML with PrP-170S was minimal. Surprisingly, in vitro PrP conversion using protein misfolding cyclic amplification (PMCA), did not reproduce the in vivo findings, suggesting that the resistance noted in live mice might be due to factors or conditions not present in vitro. These findings suggest that in vivo conversion of PrP-170S by RML and 79A scrapie strains was slow and inefficient. PrP-170S mice may be an example of the conformational selection model where the structure of some prion strains does not favor interactions with PrP molecules expressing certain polymorphisms.
Vyšlo v časopise:
Strain Specific Resistance to Murine Scrapie Associated with a Naturally Occurring Human Prion Protein Polymorphism at Residue 171. PLoS Pathog 7(9): e32767. doi:10.1371/journal.ppat.1002275
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002275
Souhrn
Transmissible spongiform encephalopathies (TSE) or prion diseases are neurodegenerative disorders associated with conversion of normal host prion protein (PrP) to a misfolded, protease-resistant form (PrPres). Genetic variations of prion protein in humans and animals can alter susceptibility to both familial and infectious prion diseases. The N171S PrP polymorphism is found mainly in humans of African descent, but its low incidence has precluded study of its possible influence on prion disease. Similar to previous experiments of others, for laboratory studies we created a transgenic model expressing the mouse PrP homolog, PrP-170S, of human PrP-171S. Since PrP polymorphisms can vary in their effects on different TSE diseases, we tested these mice with four different strains of mouse-adapted scrapie. Whereas 22L and ME7 scrapie strains induced typical clinical disease, neuropathology and accumulation of PrPres in all transgenic mice at 99-128 average days post-inoculation, strains RML and 79A produced clinical disease and PrPres formation in only a small subset of mice at very late times. When mice expressing both PrP-170S and PrP-170N were inoculated with RML scrapie, dominant-negative inhibition of disease did not occur, possibly because interaction of strain RML with PrP-170S was minimal. Surprisingly, in vitro PrP conversion using protein misfolding cyclic amplification (PMCA), did not reproduce the in vivo findings, suggesting that the resistance noted in live mice might be due to factors or conditions not present in vitro. These findings suggest that in vivo conversion of PrP-170S by RML and 79A scrapie strains was slow and inefficient. PrP-170S mice may be an example of the conformational selection model where the structure of some prion strains does not favor interactions with PrP molecules expressing certain polymorphisms.
Zdroje
1. SejvarJJSchonbergerLBBelayED 2008 Transmissible spongiform encephalopathies. J Am Vet Med Assoc 233 1705 1712
2. MooreRATaubnerLMPriolaSA 2009 Prion protein misfolding and disease. Curr Opin Struct Biol 19 14 22
3. BuelerHAguzziASailerAGreinerRAAutenriedP 1993 Mice devoid of PrP are resistant to scrapie. Cell 73 1339 1347
4. GoldmannWHunterNSmithGFosterJHopeJ 1994 PrP genotype and agent effects in scrapie: change in allelic interaction with different isolates of agent in sheep, a natural host of scrapie. J Gen Virol 75 (Pt 5) 989 995
5. HunterN 1997 PrP genetics in sheep and the applications for scrapie and BSE. Trends Microbiol 5 331 334
6. LaplancheJLChatelainJWestawayDThomasSDussaucyM 1993 PrP polymorphisms associated with natural scrapie discovered by denaturing gradient gel electrophoresis. Genomics 15 30 37
7. BenestadSLArsacJNGoldmannWNoremarkM 2008 Atypical/Nor98 scrapie: properties of the agent, genetics, and epidemiology. Vet Res 39 19
8. BenestadSLSarradinPThuBSchonheitJTranulisMA 2003 Cases of scrapie with unusual features in Norway and designation of a new type, Nor98. Vet Rec 153 202 208
9. CarlsonGAKingsburyDTGoodmanPAColemanSMarshallST 1986 Linkage of prion protein and scrapie incubation time genes. Cell 46 503 511
10. WestawayDGoodmanPAMirendaCAMcKinleyMPCarlsonGA 1987 Distinct prion proteins in short and long scrapie incubation period mice. Cell 51 651 662
11. MooreRCHopeJMcBridePAMcConnellISelfridgeJ 1998 Mice with gene targetted prion protein alterations show that Prnp, Sinc and Prni are congruent. Nat Genet 18 118 125
12. BruceMEMcConnellIFraserHDickinsonAG 1991 The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol 72 Pt 3 595 603
13. DickinsonAGMeikleVM 1969 A comparison of some biological characteristics of the mouse-passaged scrapie agents, 22A and ME7. Genet Res 13 213 225
14. GoldfarbLGPetersenRBTabatonMBrownPLeBlancAC 1992 Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258 806 808
15. MeadS 2006 Prion disease genetics. Eur J Hum Genet 14 273 281
16. BishopMTWillRGMansonJC 2010 Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci U S A 107 12005 12010
17. HeadMWBunnTJBishopMTMcLoughlinVLowrieS 2004 Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann Neurol 55 851 859
18. LeeHSBrownPCervenakovaLGarrutoRMAlpersMP 2001 Increased susceptibility to Kuru of carriers of the PRNP 129 methionine/methionine genotype. J Infect Dis 183 192 196
19. WadsworthJDAsanteEADesbruslaisMLinehanJMJoinerS 2004 Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 306 1793 1796
20. PalmerMSDrydenAJHughesJTCollingeJ 1991 Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352 340 342
21. ShibuyaSHiguchiJShinRWTateishiJKitamotoT 1998 Codon 219 Lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease. Ann Neurol 43 826 828
22. HizumeMKobayashiATeruyaKOhashiHIronsideJW 2009 Human prion protein (PrP) 219K is converted to PrPSc but shows heterozygous inhibition in variant Creutzfeldt-Jakob disease infection. J Biol Chem 284 3603 3609
23. LukicABeckJJoinerSFearnleyJSturmanS 2010 Heterozygosity at polymorphic codon 219 in variant creutzfeldt-jakob disease. Arch Neurol 67 1021 1023
24. MeadSWhitfieldJPoulterMShahPUphillJ 2009 A novel protective prion protein variant that colocalizes with kuru exposure. N Engl J Med 361 2056 2065
25. MeadSStumpfMPWhitfieldJBeckJAPoulterM 2003 Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300 640 643
26. BeckJAPoulterMCampbellTAAdamsonGUphillJB 2010 PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit. Hum Mutat 31 E1551 1563
27. YangWCookJRassbachBLemusADeArmondSJ 2009 A New Transgenic Mouse Model of Gerstmann-Straussler-Scheinker Syndrome Caused by the A117V Mutation of PRNP. J Neurosci 29 10072 10080
28. HsiaoKKScottMFosterDGrothDFDeArmondSJ 1990 Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250 1587 1590
29. NazorKEKuhnFSewardTGreenMZwaldD 2005 Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice. Embo J 24 2472 2480
30. BarronRMThomsonVKingDShawJMeltonDW 2003 Transmission of murine scrapie to P101L transgenic mice. J Gen Virol 84 3165 3172
31. BarronRMThomsonVJamiesonEMeltonDWIronsideJ 2001 Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers. Embo J 20 5070 5078
32. MansonJCJamiesonEBaybuttHTuziNLBarronR 1999 A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. Embo J 18 6855 6864
33. JacksonWSBorkowskiAWFaasHSteeleADKingOD 2009 Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice. Neuron 63 438 450
34. MastrianniJACapellariSTellingGCHanDBosqueP 2001 Inherited prion disease caused by the V210I mutation: transmission to transgenic mice. Neurology 57 2198 2205
35. DossenaSImeriLMangieriMGarofoliAFerrariL 2008 Mutant prion protein expression causes motor and memory deficits and abnormal sleep patterns in a transgenic mouse model. Neuron 60 598 609
36. ChiesaRPiccardoPGhettiBHarrisDA 1998 Neurological illness in transgenic mice expressing a prion protein with an insertional mutation. Neuron 21 1339 1351
37. SigurdsonCJNilssonKPHornemannSHeikenwalderMMancoG 2009 De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc Natl Acad Sci U S A 106 304 309
38. SigurdsonCJNilssonKPHornemannSMancoGFernandez-BorgesN 2010 A molecular switch controls interspecies prion disease transmission in mice. J Clin Invest 120 2590 2599
39. ChesebroBTrifiloMRaceRMeade-WhiteKTengC 2005 Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308 1435 1439
40. Meade-WhiteKRaceBTrifiloMBossersAFavaraC 2007 Resistance to chronic wasting disease in transgenic mice expressing a naturally occurring allelic variant of deer prion protein. J Virol 81 4533 4539
41. FischerMRulickeTRaeberASailerAMoserM 1996 Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. Embo J 15 1255 1264
42. MansonJCClarkeARHooperMLAitchisonLMcConnellI 1994 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 8 121 127
43. ShmerlingDHegyiIFischerMBlattlerTBrandnerS 1998 Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93 203 214
44. MatsunagaYPeretzDWilliamsonABurtonDMehlhornI 2001 Cryptic epitopes in N-terminally truncated prion protein are exposed in the full-length molecule: dependence of conformation on pH. Proteins 44 110 118
45. MeyerettCMichelBPulfordBSprakerTRNicholsTA 2008 In vitro strain adaptation of CWD prions by serial protein misfolding cyclic amplification. Virology 382 267 276
46. WestawayDDeArmondSJCayetano-CanlasJGrothDFosterD 1994 Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 76 117 129
47. SaaPCastillaJSotoC 2005 Cyclic amplification of protein misfolding and aggregation. Methods Mol Biol 299 53 65
48. PerrierVKanekoKSafarJVergaraJTremblayP 2002 Dominant-negative inhibition of prion replication in transgenic mice. Proc Natl Acad Sci U S A 99 13079 13084
49. PriolaSACaugheyBRaceREChesebroB 1994 Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J Virol 68 4873 4878
50. ZlotnikIRennieJC 1963 Further observations on the experimental transmission of scrapie from sheep and goats to laboratory mice. J Comp Pathol 73 150 162
51. KimberlinRHWalkerCAFraserH 1989 The genomic identity of different strains of mouse scrapie is expressed in hamsters and preserved on reisolation in mice. J Gen Virol 70 Pt 8 2017 2025
52. KimberlinRHWalkerCA 1978 Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture. J Gen Virol 39 487 496
53. CaugheyBBaronGSChesebroBJeffreyM 2009 Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem 78 177 204
54. CollingeJClarkeAR 2007 A general model of prion strains and their pathogenicity. Science 318 930 936
55. WadsworthJDAsanteEACollingeJ 2010 Review: contribution of transgenic models to understanding human prion disease. Neuropathol Appl Neurobiol 36 576 597
56. TanakaMChienPNaberNCookeRWeissmanJS 2004 Conformational variations in an infectious protein determine prion strain differences. Nature 428 323 328
57. TanakaMChienPYonekuraKWeissmanJS 2005 Mechanism of cross-species prion transmission: an infectious conformation compatible with two highly divergent yeast prion proteins. Cell 121 49 62
58. TanakaMCollinsSRToyamaBHWeissmanJS 2006 The physical basis of how prion conformations determine strain phenotypes. Nature 442 585 589
59. RaceRChesebroB 1998 Scrapie infectivity found in resistant species. Nature 392 770
60. RaceRMeade-WhiteKRainesARaymondGJCaugheyB 2002 Subclinical scrapie infection in a resistant species: persistence, replication, and adaptation of infectivity during four passages. J Infect Dis 186 Suppl 2 S166 170
61. RaceRRainesARaymondGJCaugheyBChesebroB 2001 Long-term subclinical carrier state precedes scrapie replication and adaptation in a resistant species: analogies to bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease in humans. J Virol 75 10106 10112
62. HoustonEFHallidaySIJeffreyMGoldmannWHunterN 2002 New Zealand sheep with scrapie-susceptible PrP genotypes succumb to experimental challenge with a sheep-passaged scrapie isolate (SSBP/1). J Gen Virol 83 1247 1250
63. JeffreyMGonzalezLChongAFosterJGoldmannW 2006 Ovine infection with the agents of scrapie (CH1641 isolate) and bovine spongiform encephalopathy: immunochemical similarities can be resolved by immunohistochemistry. J Comp Pathol 134 17 29
64. ThorneLTerryLA 2008 In vitro amplification of PrPSc derived from the brain and blood of sheep infected with scrapie. J Gen Virol 89 3177 3184
65. CastillaJGonzalez-RomeroDSaaPMoralesRDe CastroJ 2008 Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell 134 757 768
66. RobinsonPJPinheiroTJ 2009 The unfolding of the prion protein sheds light on the mechanisms of prion susceptibility and species barrier. Biochemistry 48 8551 8558
67. GorfeAACaflischA 2007 Ser170 controls the conformational multiplicity of the loop 166-175 in prion proteins: implication for conversion and species barrier. Faseb J 21 3279 3287
68. ChristenBPerezDRHornemannSWuthrichK 2008 NMR structure of the bank vole prion protein at 20 degrees C contains a structured loop of residues 165-171. J Mol Biol 383 306 312
69. PriolaSAChesebroB 1995 A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells. J Virol 69 7754 7758
70. KanekoKZulianelloLScottMCooperCMWallaceAC 1997 Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci U S A 94 10069 10074
71. PriolaSAChabryJChanK 2001 Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155. J Virol 75 4673 4680
72. VorbergIGroschupMHPfaffEPriolaSA 2003 Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform. J Virol 77 2003 2009
73. GoldmannWHunterNFosterJDSalbaumJMBeyreutherK 1990 Two alleles of a neural protein gene linked to scrapie in sheep. Proc Natl Acad Sci U S A 87 2476 2480
74. O'RourkeKIHolyoakGRClarkWWMickelsonJRWangS 1997 PrP genotypes and experimental scrapie in orally inoculated Suffolk sheep in the United States. J Gen Virol 78 ) Pt 4 975 978
75. FinckhUMuller-ThomsenTMannUEggersCMarksteinerJ 2000 High frequency of mutations in four different disease genes in early-onset dementia. Ann N Y Acad Sci 920 100 106
76. ReveszTHoltonJLLashleyTPlantGFrangioneB 2009 Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies. Acta Neuropathol 118 115 130
77. GoldfarbLGBrownPHaltiaMCathalaFMcCombieWR 1992 Creutzfeldt-Jakob disease cosegregates with the codon 178Asn PRNP mutation in families of European origin. Ann Neurol 31 274 281
78. NozakiIHamaguchiTSanjoNNoguchi-ShinoharaMSakaiK 2010 Prospective 10-year surveillance of human prion diseases in Japan. Brain 133 3043 3057
79. SamaiaHBMariJJValladaHPMouraRPSimpsonAJ 1997 A prion-linked psychiatric disorder. Nature 390 241
80. ApplebyBSApplebyKKHallRCWallinMT 2010 D178N, 129Val and N171S, 129Val genotype in a family with Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 30 424 431
81. SchatzlHMDa CostaMTaylorLCohenFEPrusinerSB 1995 Prion protein gene variation among primates. J Mol Biol 245 362 374
82. ChandlerRL 1961 Encephalopathy in mice produced by inoculation with scrapie brain material. Lancet 1 1378 1379
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 9
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Hostile Takeover by : Reorganization of Parasite and Host Cell Membranes during Liver Stage Egress
- HTLV-1 Propels Thymic Human T Cell Development in “Human Immune System” Rag2 gamma c Mice
- Exploiting and Subverting Tor Signaling in the Pathogenesis of Fungi, Parasites, and Viruses
- A Viral Ubiquitin Ligase Has Substrate Preferential SUMO Targeted Ubiquitin Ligase Activity that Counteracts Intrinsic Antiviral Defence